C2orf60_1110034B05Rik Activators
The activation and functional enhancement of C2orf60 are influenced by a variety of chemical compounds that modulate distinct cellular signaling pathways, indirectly leading to its potential upregulation or increased activity. Forskolin and IBMX, by elevating intracellular levels of cAMP, along with Dibutyryl-cAMP, a synthetic cAMP analog, stimulate cAMP-dependent protein kinase A (PKA), which could then enhance C2orf60's functional activities in cellular signaling networks. Similarly, Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), suggesting another avenue through which C2orf60 activity could be indirectly enhanced, by engaging with signaling pathways that intersect with PKC's broad cellular roles. These compounds exemplify how modulation of intracellular signaling mediators can lead to the indirect activation of C2orf60, highlighting the intricate interplay between diverse signaling pathways and this specific protein.
Further complexity in the regulation of C2orf60 activity is introduced by compounds that target PI3K and MAPK pathways, such as LY294002, Wortmannin, U0126, and SB203580. These inhibitors potentially shift cellular signaling dynamics in a manner that indirectly enhances C2orf60's role in the cell, either by altering feedback loops or by modifying the activity of signaling networks that C2orf60 is a part of. Additionally, compounds like Epigallocatechin gallate (EGCG) and Sphingosine-1-phosphate (S1P) modulate cellular responses to oxidative stress and sphingolipid signaling, respectively, which could indirectly influence C2orf60 activity through redox-sensitive and sphingolipid-dependent mechanisms. The potential for Thapsigargin and A23187 to raise intracellular calcium levels offers another dimension of regulatory influence, engaging calcium-dependent signaling pathways that could enhance C2orf60's functional involvement in cellular processes. Together, these activators depict a multifaceted framework through which C2orf60 activity could be enhanced, underscoring the complexity of cellular signaling networks and the diverse mechanisms that can influence protein function.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a nonspecific inhibitor of phosphodiesterases, increasing intracellular cAMP and cGMP levels, potentially enhancing C2orf60 signaling through cAMP/cGMP-dependent pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC), which could enhance C2orf60 activity by modulating signaling pathways that intersect with PKC, potentially influencing C2orf60's functional role. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG, a potent antioxidant, might indirectly activate C2orf60 by modulating redox-sensitive signaling pathways or proteins that interact with or regulate C2orf60 activity. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P, through its receptors, could activate signaling cascades that indirectly enhance C2orf60 activity, particularly in pathways related to cell survival and proliferation where C2orf60 might play a role. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, might indirectly enhance C2orf60 activity by altering signaling pathways that converge on or are modulated by PI3K, potentially affecting pathways C2orf60 is involved in. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126, a MEK inhibitor, could indirectly enhance C2orf60 function by modulating the MAPK/ERK pathway, affecting downstream signaling processes where C2orf60 might be implicated. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580, a p38 MAPK inhibitor, might indirectly activate C2orf60 by altering cellular stress response pathways or other signaling mechanisms that interact with C2orf60's function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin, another PI3K inhibitor, could indirectly enhance C2orf60 activity by impacting signaling pathways that affect cellular processes C2orf60 is involved in. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin raises intracellular calcium levels, potentially enhancing C2orf60 activity through calcium-dependent signaling pathways. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP, a cAMP analog, can mimic the action of endogenous cAMP, potentially enhancing C2orf60 activity by activating cAMP-dependent signaling pathways. | ||||||